期刊文献+

临床常见致病菌的药敏研究 被引量:1

Study on antibacterial activities in vitro of common clinical bacteria
下载PDF
导出
摘要 目的:对比研究140株临床分离细菌对常用头孢菌素及喹诺酮类抗菌素的体外敏感性。方法:采用琼脂平板稀释法测定最低抑菌浓度(M IC)。结果:头孢地尼、加替沙星、左氧氟沙星、头孢克罗、头孢拉定、头孢氨苄对革兰阳性菌的敏感率均大于70%。对大肠埃希菌,头孢地尼、加替沙星、左氧氟沙星的体外抗菌活性强于其他抗菌素。对肺炎克雷伯菌的抗菌活性,头孢地尼、头孢克肟显著强于其他4种抗菌素。对变形杆菌,头孢地尼、头孢克肟及左氧氟沙星的抗菌活性相近。结论:头孢地尼、加替沙星、左氧氟沙星对大部分革兰阳性及革兰阴性菌具有较强的抗菌活性。 Objective: To evaluate antibacterial activities in vitro of antibiotics. Methods: Minimal inhibitiory concentration (MIC) was determined by agar disk dilution method. Results:The sensitive rates of cefdinir, gatifloxacin, levofloxacin, cefclor, cefradine and cefhaloxine were over 70%. The antibacterial activities of cefdinir, cefixime, levofloxacin and gatifloxacin against S. Pneumonia were higher than other four. The antibacterial activities of cefdinir, levofloxacin and gatifloxacin against E. coli were higher than other five. The antibacterial activities of cefdinir, cefixime, and levofloxacin against Pr. Were similar, but higher than others. Conclusion:Cefdinir, gatifloxacin and levofloxacin has strong antibacterial activity in vitro against G^+ and G^- bacterium.
机构地区 解放军 解放军
出处 《中国卫生检验杂志》 CAS 2007年第6期1059-1061,共3页 Chinese Journal of Health Laboratory Technology
关键词 临床致病菌 药敏 Clinical bacterium Antibacterial activity
  • 相关文献

参考文献7

  • 1Balows A,Hasler WJ,Herrman KL,et al.Manal of clinical microbiology[M].6th ed.Washinghton DC:American Society for Microbiology,1995.209.
  • 2Performance standards for antimicrobial susceptibility testing sixteenth informational supplement.2006 年 CLSI/NCCLS 文件 m100-s16,26(3).
  • 3Chatterjee A,Moland ES.Cefdinir an oral alternative to parenteral cephems[J].Dign Microbiol Infect Dis,2005,51 (4):259 -264.
  • 4Margaret Drehobel,PatricBianchi.Comparison of cefdinir and cefaclor in treatment of community-acquired pneumonia:antimicrobial agents and chemotherapy[J].1997,7(11):1579 -1583.
  • 5Diekema DJ,Pfaller MA.Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with blood-stream in the USA,Canada and Latin America[J].Int J Antimicrob Agents,2000,13 (4):257-271.
  • 6Perry CM,Scott LJ.Cefdinir a review of its use in the management of mild-to-moderate bacterial infections[J].Drugs,2004,64 (13):1433-1464.
  • 7Dennis M,Grasel S.Clinical pharmacology of gatifloxacin,a new fluoroquinolone[J].Clinical Infect Dis,2000,31 (Suppl 2):S51-58.

同被引文献11

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部